Polyquaternary ammonium salt as well as antibacterial and antiviral particles and application thereof

By adjusting the structure of polyquaternary ammonium macromolecules and the "carbide layer" of nanotitanium dioxide, the durability and compatibility problems of polyquaternary ammonium materials are solved, and the balance between efficient antibacterial and biocompatibility is achieved, and the system has been expanded. Application scope and improve stability and safety.

CN118930718APending Publication Date: 2024-11-12HANGZHOU MICRONANO WEIKANG NEW MATERIAL CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202410980533.4
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-22
Publication Date
2024-11-12

AI Technical Summary

Technical Problem

During the use of existing antibacterial materials, there are problems with poor durability, strong toxicity, high cost, and production complexity and compatibility. In particular, the hydrophobic components of polyquaternary ammonium salt materials have a great impact on antibacterial properties but are difficult to regulate. The literature Data and conclusions on the antibacterial properties of long carbon chains are not involved.

Method used

By designing the A, B and C segment structures in polyquaternary ammonium salt macromolecules, adjusting the proportion of repeating units and the length of the hydrophobic component alkyl chains, combining non-ionic surfactants and initiators to form antibacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bacterial anti-bact Virus particles optimize the balance of antibacterial and biocompatibility, and improve biocompatibility and UV resistance through nanotitanium dioxide "carbide layer".

Benefits of technology

It has achieved high efficiency and good biocompatibility of antibacterial and antiviral particles, expanded the application scope of polyquaternary ammonium salt materials, especially in the fields of medical devices and textiles, and has better stability and safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118930718A_ABST
    Figure CN118930718A_ABST
Patent Text Reader

Abstract

The invention relates to the technical field of antibacterial materials, and particularly discloses a polyquaternary ammonium salt which at least comprises a chain segment A, a chain segment B and a chain segment C, the side chain of the chain segment A contains a quaternary ammonium salt group, the side chain of the chain segment B contains a C8-C22 alkyl chain, and the side chain of the chain segment C contains at least one of a C1-C6 alkyl chain, a phenyl group, a cyano group, a carboxyl group and a sulfonic group. The invention also discloses three antibacterial and antiviral particles. The first antibacterial and antiviral particle comprises the polyquaternary ammonium salt. The second antibacterial and antiviral particle comprises a reaction product of the polyquaternary ammonium salt and a reactive component. The third antibacterial and antiviral particle is obtained by mixing polyvinyl alcohol, the polyquaternium, glucose and the like and then carrying out hydrothermal reaction. The invention further discloses application of the three antibacterial and antiviral particles in medical instruments and the like. According to the invention, a polyquaternium group and a long alkyl chain group are taken as main change parameters, and the balance of antibacterial property and biocompatibility of the polyquaternium is realized by combining the size effect of particles.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of antibacterial materials, and in particular to a polyquaternary ammonium salt and antibacterial and antiviral particles thereof and applications thereof. Background Art

[0002] Antibacterial materials have a wide range of application needs in the fields of textiles, non-woven fabrics, plastics, fibers, medical devices, etc. For example, in the field of textiles, since textiles are often in contact with the human body, a large amount of human excrement and dead cells / tissues will accumulate. Under the influence of human body temperature, these substances will provide excellent conditions for bacterial reproduction, causing the textiles to stink and even causing bacterial infections on the surface of the body. In the field of medical devices, especially interventional devices, the colonization of pathogenic microorganisms on the surface of the device will produce toxins and other metabolites, leading to acute systemic infection; it may even cause septic shock and migratory lesions, posing a great threat to the patient's life and property. Therefore, the widespread use of antibacterial materials can not only improve the comfort of people's lives and avoid odor or mildew caused by bacteria, but also effectively protect people's health and improve their quality of life during the medical process.

[0003] With the progress of society and the development of science and technology, the selection of antibacterial materials is very wide. Common antibacterial materials include: inorganic antibacterial agents, organic antibacterial agents and natural antibacterial agents. The basic principle of inorganic antibacterial agents represented by silver ions / nanosilver is to use the released silver ions to inactivate the intracellular endotoxins by affecting the selective permeability of bacterial cells. However, inorganic antibacterial agents have poor compatibility with organic polymers and are prone to migration. With the use or washing operations, they will gradually lose their antibacterial effect. Natural antibacterial agents are mainly derived from biological extracts, including chitosan, chitin, biopeptides and other substances. They have the characteristics of low toxicity, good biocompatibility and easy decomposition, but their short service life and high price limit their scope of application. Organic antibacterial agents mainly include organic acids, quaternary ammonium salts, benzimidazoles, etc., which have strong bactericidal efficacy, but their strong toxicity and poor durability limit their scope of use.

[0004] Small molecule quaternary ammonium salts represented by benzalkonium chloride are a type of commonly used antibacterial and antiviral raw materials. Due to their small molecular weight and cationic characteristics, they are easy to combine and penetrate with anionic animal / human cell membranes, bacterial cell walls, and viral envelopes, causing certain irritation to animals / human bodies, while destroying the structure of bacteria / viruses and killing bacteria or viruses. Moreover, this small molecule quaternary ammonium salt is highly soluble in water. During use, it will be lost during water washing or wiping, and thus has poor durability.

[0005] To address this problem, researchers have developed a series of polyquaternary ammonium materials.

[0006] Patent CN106565912B discloses a polyquaternary ammonium salt polymer emulsion antibacterial agent, which includes a cationic monomer, an initiator, water, a hard monomer, a soft monomer, a water resistance functional monomer, a cross-linking functional monomer, and an adhesion functional monomer, etc. The patent focuses on the characteristics of this type of antibacterial agent, such as strong antibacterial properties, no dissolution, and good durability. At the same time, in order to enhance the stability of the antibacterial agent, a polyurethane curing agent is used to achieve full cross-linking and curing of the NCO group in the skeleton and the OH group in the antibacterial agent.

[0007] Patent CN108948250B discloses an antibacterial polymer emulsion, which is composed of specific non-antibacterial monomers, including styrene, butyl acrylate, methacrylic acid, vinyl trimethoxysilane and ethyl acetoacetate methacrylate, and antibacterial monomers, including quaternary ammonium salt cationic monomers or betaine monomers. The patent focuses on the antifungal properties of the polymer.

[0008] Patent CN110437374B discloses a quaternary amphiphilic cationic polymer, whose cationic N,N,N-trimethylammonium ethyl methacrylate is used, and the hydrophobic monomer is n-alkyl methacrylate, wherein the carbon number of the n-alkyl methacrylate is 3 to 8. The hydrophilic and hydrophobic ratio of the polymer is adjusted by introducing polyethylene glycol chain segments to optimize the balance between antibacterial and biocompatibility.

[0009] Patent CN109705262B discloses a cationic antibacterial polymer - methyl methacrylate-CO-dimethylaminoethyl methacrylate-ethyl bromide copolymer, which adjusts the antibacterial and biocompatibility of the polymer by adjusting the ratio of the antibacterial segment (also the hydrophilic segment) to the hydrophobic segment.

[0010] Patent CN106084203B discloses a water-soluble block polyquaternary ammonium salt polymer material and a preparation method thereof. By changing the molecular weight of polyethylene glycol in the macromolecular initiator, polymers with different polyethylene glycol and quaternary ammonium salt contents are constructed to achieve lubricity, moisture retention and broad-spectrum antibacterial properties.

[0011] Patent CN106794277B discloses a sanitary product and a sanitary product treating agent, which mainly involve a water-soluble cationic polymer. The main characteristics of this series of polyquaternary ammonium salts are that the anions thereof are methyl sulfonate or ethyl sulfonate and have good water solubility.

[0012] The morphology of antimicrobial agents is another factor that affects the antimicrobial effect, such as the nanosilver mentioned above. Wang Yao et al. (Relationship between Nanosilver Particle Size and Antibacterial Performance [J]. China Leather, 2016(5):4. DOI:10.13536 / j.cnki.issn1001-6813.2016-005-001.) showed that 37nm nanosilver has the best anti-Escherichia coli effect, and 23nm nanosilver has the best anti-Staphylococcus aureus effect. The antibacterial effect of particles below or above this range will be significantly reduced. Similarly, for nano-copper oxide and nano-zinc oxide materials, the size effect also has a great impact on antibacterial properties.

[0013] Compared with inorganic nanomaterials, organic antibacterial particles have greater advantages. First, from the perspective of synthesis, commercially available nanometal antibacterial materials are all obtained by grinding metals, but the grinding energy consumption and grinding equipment requirements from macroscopic materials to nanomaterials are very high, which limits the production of high-quality nanomaterials with stable performance; while the production of organic particles can start from monomers, and through the method of emulsion / suspension polymerization, it is easier to regulate the particle size of organic particles and easier to enlarge. Secondly, the potential harm of inorganic nanoparticles to organisms has received extensive attention and discussion, while the structure of organic particle materials is easier to adjust, and at the same time, it has better compatibility with organic adhesives, fibers, plastics, etc., and is easier to combine with substrates, effectively avoiding the potential caused by particle shedding. Finally, nanomaterials have high surface energy and are prone to agglomeration, which affects their processing performance. Therefore, it is generally necessary to modify the surface of nanoparticles to enhance dispersibility and optimize their processing performance; while organic particles, especially the polyquaternary ammonium salt organic particles involved in the present invention, have their own static charge, effectively enhance the repulsive force between particles, and have better processing performance.

[0014] Those skilled in the art can effectively adjust the hydrophilicity, adhesive properties, antibacterial properties and biocompatibility of polyquaternary ammonium salts by changing the types and compositions of monomers in polyquaternary ammonium salts. However, the following problems are also found:

[0015] (1) The evaluation of polyquaternary ammonium salts in the relevant literature is based on the polymer composition. However, since polyquaternary ammonium salts, especially those containing hydrophobic components, have amphiphilic characteristics, they usually exist in the form of particles (or nanoparticles, micelles, vesicles, etc.) in water or other solvents. The relevant literature does not involve the influence of its physical structure factors on its performance;

[0016] (2) The structure of polyquaternary ammonium salts tends to be complex, which increases the difficulty of synthesis and production costs. On the other hand, it increases the difficulty of polymer structure analysis, resulting in inaccurate structure-activity relationship analysis.

[0017] (3) In addition to the fact that the content of the hydrophobic component in polyquaternary ammonium salts has a significant impact on the antibacterial properties, the chain length of the alkyl chain of the hydrophobic component (especially the chain length of 8 carbons or more) also has a significant impact on the antibacterial properties and other properties.

[0018] The relevant literature does not involve data and conclusions on the size effect of long carbon chains on the coated and bound particles of quaternary ammonium salt groups. Summary of the invention

[0019] The purpose of the present invention is to solve the problems existing in the prior art and to propose a polyquaternary ammonium salt and its antibacterial and antiviral particles and applications.

[0020] A polyquaternary ammonium salt comprises at least: an A segment, a B segment and a C segment; the side chain of the A segment contains a quaternary ammonium salt group, the side chain of the B segment contains a C8-C22 alkyl chain, and the side chain of the C segment contains at least one of a C1-C6 alkyl chain, a phenyl group, a cyano group, a carboxyl group and a sulfonic acid group; wherein the sum of the number of repeating units of each segment in the polyquaternary ammonium salt is n, the number of repeating units of the A segment is a, and the number of repeating units of the B segment is b, then n, a and b meet the following relationship: (a+b) / n≥0.6, and 0.1≤a / (a+b)≤0.5.

[0021] The preparation method of the polyquaternary ammonium salt comprises the following steps: mixing the reaction monomer of the A segment, the reaction monomer of the B segment, the reaction monomer of the C segment, a nonionic surfactant and water, heating the mixture to 70-80° C., and then dropping an initiator for reaction to obtain the polyquaternary ammonium salt.

[0022] Preferably, the mass of the nonionic surfactant is m1, the sum of the masses of the reactive monomers of segment A, segment B and segment C is m2, and the total system mass is m3, then m1 / m2=1±0.1%, m2 / m3=30±5%.

[0023] Preferably, the nonionic surfactant is at least one of Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60 and Tween 80.

[0024] Preferably, the initiator is ammonium persulfate.

[0025] The present invention focuses on the synergistic effect between the A segment and the B segment, promoting the antibacterial effect and the balance between the antibacterial and biocompatibility in the particle state. The present invention limits the content of the A segment and the B segment in the polyquaternary ammonium salt macromolecule, and the proportion of the A segment to ensure the antibacterial property of the polyquaternary ammonium salt, and the long alkyl chain characteristics of the B segment have the following two mechanisms: first, when the long alkyl chain contacts the bacteria with the quaternary ammonium salt group, there will be a significant membrane penetration process, and the quaternary ammonium salt group will promote the destruction of the cell membrane; second, the long alkyl group has a certain stretchability in the solution, and the long alkyl chain in the same polyquaternary ammonium salt molecule or the adjacent polyquaternary ammonium salt molecule will cover or partially cover the quaternary ammonium salt group, which can "shield" the destructive effect of the polyquaternary ammonium salt on the biological cell membrane, thereby achieving a balance between antibacterial property and biocompatibility.

[0026] Preferably, if the side chain of the B segment is a C8-C14 alkyl chain, then 0.1≤a / (a+b)≤0.4; if the side chain of the B segment is a C16-C22 alkyl chain, then 0.2≤a / (a+b)≤0.5. Alkyl chains of different lengths have different effects on the balancing effect. When the alkyl chain is short, the shielding effect is poor and the antibacterial effect is weakened; when the alkyl chain is long, the shielding effect is good and the antibacterial effect is weakened more significantly.

[0027] Preferably, the reactive monomer of segment A is at least one of (meth)acryloyloxyethyltrimethylammonium chloride, (meth)acryloyloxyethyltrimethylammonium bromide, (meth)acryloyloxyethyltrimethylammonium iodide, (meth)acryloyloxyethyldimethylbenzylammonium chloride, (meth)acryloyloxyethyldimethylbenzylammonium bromide, (meth)acryloyloxyethyldimethylbenzylammonium iodide, (meth)acryloyloxyethyldimethylisopropylammonium chloride, (meth)acryloyloxyethyldimethylisopropylammonium bromide, and (meth)acryloyloxyethyldimethylisopropylammonium iodide; preferably (meth)acryloyloxyethyldimethylbenzylammonium chloride, (meth)acryloylethoxydimethylbenzylammonium bromide or / and (meth)acryloyloxyethyldimethylbenzylammonium iodide.

[0028] Preferably, the reactive monomer of the B segment is at least one of octyl (meth)acrylate, decyl (meth)acrylate, dodecyl (meth)acrylate, tetradecyl (meth)acrylate, hexadecyl (meth)acrylate, octadecyl (meth)acrylate, eicosyl (meth)acrylate, and docosyl (meth)acrylate.

[0029] Preferably, the reactive monomer of the C segment is at least one of methyl (meth)acrylate, butyl acrylate, methacrylic acid, styrene, acrylonitrile, allyl polypropylene glycol ether, and 2-acrylamide-2-methylpropane sulfonic acid.

[0030] Preferably, the polyquaternary ammonium salt further comprises: a D segment, the side chain of which contains at least one of a hydroxyl group, an amine group, an epoxy group, an azide group, a hydroxymethyl group, an organosilicon group, and a carbon-carbon double bond; the number of repeating units of the D segment is d, then 0.005≤d / n≤0.1.

[0031] Preferably, the reactive monomer of the D segment is at least one of hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, hydroxyethyl methacrylate, glycidyl methacrylate, N,N-dimethylaminoethyl methacrylate, methacryloxytrimethoxysilane, methacryloxytriethoxysilane, methacryloxytriisopropoxysilane, diacetone acrylamide, acetoacetoxyethyl methacrylate, and methacrylate polyethylene glycol azide.

[0032] The preparation method of the polyquaternary ammonium salt comprises the following steps: mixing reaction monomers of segment A, segment B, segment C, segment D, a nonionic surfactant and water, heating to 70-80° C., and then dropping an initiator for reaction to obtain the polyquaternary ammonium salt.

[0033] Preferably, the mass of the nonionic surfactant is m1, the sum of the masses of the reactive monomers of segment A, segment B, segment C and segment D is m2, and the total system mass is m3, then m1 / m2=1±0.1%, m2 / m3=30±5%.

[0034] Preferably, the nonionic surfactant is at least one of Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60 and Tween 80.

[0035] Preferably, the initiator is ammonium persulfate.

[0036] An antibacterial and antiviral particle comprises: the polyquaternary ammonium salt composed of an A segment, a B segment and a C segment.

[0037] The present invention needs to emphasize that the performance of the antibacterial and antiviral particles obtained by using the polyquaternary ammonium salt composed of A segment, B segment and C segment is significantly different from that of the polyquaternary ammonium salt composed of A segment, B segment and C segment. The particle state, due to its structural characteristics, will form two parts, the particle interior and the particle cortex, and there will be differences in its performance expression. In general, the particle interior will not have a significant effect on the antibacterial and biocompatibility of the particle, while the particle cortex has the most direct effect on the antibacterial and biocompatibility. Since the polyquaternary ammonium salt will cause the difference in the distribution of each component inside the particle due to the difference in solvent characteristics during the particle formation process. If the quaternary ammonium salt with an antibacterial composition tends to be enriched on the particle surface, the particle exhibits stronger antibacterial and poorer biocompatibility than the polyquaternary ammonium salt; on the contrary, if the quaternary ammonium salt with an antibacterial composition tends to be enriched inside the particle, the particle exhibits weaker antibacterial and better biocompatibility than the polyquaternary ammonium salt.

[0038] Preferably, the antibacterial and antiviral particles can be dispersed in water, or dissolved in a solvent; the solvent is at least one of N,N-dimethylacetamide, N,N-dimethylformamide, tetrahydrofuran, acetone, and N-methylpyrrolidone.

[0039] As for the characteristics of the antibacterial and antiviral particles, the particles are generally dispersed in water, which can be in the form of emulsion or suspension, which is directly related to its preparation method. From its structure, it can be seen that the particles are aggregated only by hydrophobic interaction, and no cross-linking structure is formed. Therefore, the particles can be dissolved in some polar solvents, including N,N-dimethylacetamide, N,N-dimethylformamide, tetrahydrofuran, acetone, N-methylpyrrolidone, etc.

[0040] Another antibacterial and antiviral particle comprises: a reaction product of the above-mentioned polyquaternary ammonium salt composed of segment A, segment B, segment C and segment D and a reactive component.

[0041] Preferably, the reactive component is at least one of glutaraldehyde, hexamethylene diisocyanate, isophorone diisocyanate, toluene diisocyanate, ethylenediamine, diethylenediamine, dibutylene diamine, diacetone acrylamide, ethyl acetoacetoxy methacrylate, dithiol polyethylene glycol, dimercaptosuccinic acid, and 2,5-dimercaptoterephthalic acid.

[0042] The preparation method of the antibacterial and antiviral particles comprises: dispersing the polyquaternary ammonium salt in water, adding reactive components and mixing, and reacting at 25-80° C. for 7-9 hours.

[0043] Preferably, the antibacterial and antiviral particles are dispersible in water but cannot be dissolved in a solvent.

[0044] The biggest difference between the two antibacterial and antiviral particles lies in the cross-linked structure inside the particles. Since the D component is introduced into the polyquaternary ammonium salt and reacts with the reactive component at the same time, a cross-linked network is constructed through the chemical reaction between the reactive groups on the D segment and the reactive component, making the particles with the cross-linked structure inside insoluble in the solvent.

[0045] For example, when the antibacterial and antiviral particles based on polyquaternary ammonium salts contain active groups such as hydroxyl or amino, the active groups are easily reacted with reactive components such as glutaraldehyde, hexamethylene diisocyanate, isophorone diisocyanate, toluene diisocyanate, etc. to form alcohols, esters, Schiff bases or polyurethanes;

[0046] When the antibacterial and antiviral particles based on polyquaternium salts contain active groups such as epoxy groups, such active groups are easily reacted with reactive components such as ethylenediamine, diethylenediamine, and dibutylene diamine;

[0047] When the antibacterial and antiviral particles based on polyquaternary ammonium salts contain active groups such as carbon-carbon double bonds, such active groups are easily reacted with diacetone acrylamide, acetoacetoxyethyl methacrylate, etc.

[0048] In short, reactive groups are introduced into antibacterial and antiviral particles based on polyquaternary ammonium salts through molecular design, and by selecting appropriate reactive components, adjusting the material ratio, reaction conditions, etc., antibacterial and antiviral particles with internal cross-linked structures and insoluble in solvents are obtained.

[0049] The particle sizes of the two antibacterial and antiviral particles are 20 to 2000 nm, and the surface potentials are 10 to 80 mV.

[0050] The "particles" proposed in the present invention are significantly different from "nanoparticles" or "nanoparticles". The particle size of the particles of the present invention ranges from 20 to 2000 nm. According to the definition of nanomaterials, particles in the range of 20 to 100 nm can be called nanoparticles or nanoparticles; and when the particle size is greater than 100 nm, it cannot be called a nanoparticle but only a "particle".

[0051] The positive charge on the surface of antibacterial and antiviral particles is a significant feature of the particles. This positive charge is related to the quaternary ammonium salt content in the particles. Too high or too low surface potential will affect the comprehensive performance of the particles. If the surface potential is too low, on the one hand, it indicates that the quaternary ammonium salt groups are insufficient, resulting in insufficient antibacterial properties; on the other hand, the electrostatic repulsion between the particles is insufficient, affecting the stability of the particles; if the surface potential is too high, it means that the quaternary ammonium salt content in the particles is too high, exceeding the adjustable range of its antibacterial properties and biological biocompatibility.

[0052] The aqueous dispersions of the two antibacterial and antiviral particles can be separated by centrifugation, heating or filtering, and can be fused under the combined action of heating and a fusion promoter.

[0053] The purification method of antibacterial and antiviral particles is a method of converting particles from their liquid dispersion to solid or other forms, which not only demonstrates the feasibility of their liquid processing form, but also satisfies the feasibility of solid processing form. The centrifugation, heating or filtration obtained in the present invention are all methods for separating particles and liquid media in liquid dispersions. The difference between these methods is related to the dispersant system of the particle dispersion, the particle size and the drying method, etc., and needs to be judged according to the actual situation.

[0054] The antibacterial and antiviral particles fuse under heating or the action of a fusion promoter, which illustrates the state change of the particles during the application process. For the fusion process, the heating temperature is 60 to 150°C, preferably 70 to 90°C; the fusion promoter is one or more of water, ethanol, methanol, and glycerol. On the one hand, the processing conditions are related to the thermal properties of the polyquaternary ammonium salt, especially its glass transition temperature; on the other hand, they are also related to its hydrophilic and hydrophobic ratio. The solvation of water or alcohol is conducive to the fusion of particles during the heating process.

[0055] Through the fusion of particles, the processing form of the coating can be realized. The dispersion of such particles can be processed onto the surface of textiles, non-woven fabrics, plastics, fibers, and even medical devices to achieve surface functionalization. The fusion of particles also greatly promotes the stability of the coating, thereby improving the safety of the coating itself.

[0056] The applicant further improved the above-mentioned polyquaternary ammonium salt and prepared it by the following specific operation: adding polyvinyl alcohol, the above-mentioned polyquaternary ammonium salt and glucose to deionized water and stirring evenly, adding tetrabutyl titanate thereto and stirring for 1 to 5 minutes, adding ammonia water dropwise thereto under stirring, continuing stirring for 1 to 2 hours, hydrothermally reacting at 95 to 110° C. for 10 to 15 hours, filtering, washing with water, and drying to obtain antibacterial and antiviral particles.

[0057] Preferably, the mass ratio of polyvinyl alcohol, the above-mentioned polyquaternary ammonium salt, glucose and tetrabutyl titanate is 1-2:5-10:1-3:1-3.

[0058] Preferably, the mass fraction of aqueous ammonia is 15-20%.

[0059] The present invention disperses polyquaternary ammonium salt in water, deposits nano titanium dioxide on the surface thereof, and then forms a "carbonized layer" bonded to the surface through hydrothermal treatment, which can effectively "shield" the destructive effect of polyquaternary ammonium salt on biological cell membranes. Experiments have also found that the antibacterial and antiviral particles can have better biocompatibility while maintaining the original antibacterial properties of polyquaternary ammonium salt; in addition, the titanium dioxide "carbonized layer" improves the ultraviolet resistance of the antibacterial and antiviral particles.

[0060] The antibacterial rate of the three antibacterial and antiviral particles against Escherichia coli is greater than 99%, the antiviral activity rate against influenza A virus H1N1 is greater than 99%, and the in vitro cytotoxicity is level 0 to 1.

[0061] Due to the destructive effect of quaternary ammonium salts on the envelope structure, they have a killing effect not only on bacteria, but also on viruses containing envelopes. Therefore, they also have antibacterial and antiviral effects.

[0062] The present invention takes quaternary ammonium salt groups and long alkyl chain groups (chain length is more than 8 carbon atoms) as main variable parameters, and combines the size effect of particles to successfully design and synthesize a class of polyquaternary ammonium salts with relatively simple composition, achieves a balance between antibacterial and biocompatibility, and applies the polyquaternary ammonium salts to medical devices with higher safety requirements in addition to traditional applications such as textiles, non-woven fabrics, plastics, and fibers, thereby greatly broadening the application scope of the polyquaternary ammonium salt materials. BRIEF DESCRIPTION OF THE DRAWINGS

[0063] Figure 1 This is a scanning electron microscope image of the antibacterial and antiviral functionalized non-woven fabric obtained in Example 1.

[0064] Figure 2 This is a comparison chart of the logarithmic change of the bacterial count of the antibacterial and antiviral particles obtained in Example 10 and Example 19 after being cultured with a Staphylococcus aureus suspension after being irradiated with ultraviolet light for different periods of time relative to the bacterial count of the blank control group. DETAILED DESCRIPTION

[0065] The present invention will be further explained below in conjunction with specific embodiments.

[0066] The following antibacterial evaluation method refers to: GB / T 20944.3-2008 "Evaluation of antibacterial properties of textiles Part 3: Oscillation method".

[0067] The following antiviral evaluation method refers to: ISO 18184-2019 "Determination of antiviral activity of textiles".

[0068] The evaluation methods of biocompatibility include hemolysis, skin irritation, sensitization and in vitro cytotoxicity, etc. The following groups adopt in vitro cytotoxicity evaluation, and the method refers to: GB / T16886.5-2017 "Biological Evaluation of Medical Devices-In Vitro Cytotoxicity".

[0069] Example 1

[0070] Methacryloyloxyethyl trimethylammonium chloride (4.1 g, 20 mM), octyl methacrylate (9.9 g, 50 mM), methyl methacrylate (3.0 g, 30 mM), Tween 80 (2.0 g) and deionized water (40 g) were added to a reaction bottle and mixed, mechanically stirred for 30 min under a nitrogen atmosphere, then heated to 75 ° C, and then APS aqueous solution (5 mL, 0.5 mol / L) was added dropwise. After reacting for 6 hours, the antibacterial and antiviral particles were obtained after cooling, purification, and drying; or after purification, they were redispersed in water to obtain an antibacterial and antiviral particle dispersion.

[0071] Characterization of polymer structure and properties:

[0072] (1) Structural characterization: 1H-NMR was used to analyze the copolymer structure; laser dynamic light scattering was used to test the particle size of the antibacterial and antiviral particles;

[0073] (2) Performance characterization: The surface potential of the antibacterial and antiviral particles was tested using the particle potential test mode of a laser dynamic light scattering instrument.

[0074] The above-mentioned antibacterial and antiviral particles are treated with a non-woven fabric using a padding process (the concentration of the antibacterial and antiviral particles based on polyquaternary ammonium salt in the coating liquid is 1%, the liquid rate in the padding process is 100%, the drying temperature is 120°C, and the drying time is 10 minutes) to obtain an antibacterial and antiviral functionalized non-woven fabric.

[0075] The antibacterial and antiviral functionalized nonwoven fabrics were evaluated for their antibacterial and antiviral properties, antiviral activity, and biocompatibility. The distribution of antibacterial and antiviral particles on the nonwoven fabric fibers was observed using a scanning electron microscope.

[0076] Distribution of antibacterial and antiviral particles on nonwoven fibers Figure 1 shown.

[0077] Example 2

[0078] Acryloyloxyethyl trimethylammonium bromide (7.1g, 30mM), decyl acrylate (8.5g, 40mM), ethyl methacrylate (3.4g, 30mM), Tween 80 (2.0g) and deionized water (47g) were added to a reaction bottle, mixed, mechanically stirred for 30min under a nitrogen atmosphere, then heated to 75°C, and then APS aqueous solution (5mL, 0.5mol / L) was added dropwise. After reacting for 7h, the antibacterial and antiviral particles were obtained after cooling, purification and drying; or after purification, they were redispersed in water to obtain an antibacterial and antiviral particle dispersion.

[0079] Characterization of polymer structure and properties:

[0080] (1) Structural characterization: 1H-NMR was used to analyze the copolymer structure; laser dynamic light scattering was used to test the particle size of the antibacterial and antiviral particles;

[0081] (2) Performance characterization: The surface potential of the antibacterial and antiviral particles was tested using the particle potential test mode of a laser dynamic light scattering instrument.

[0082] The above-mentioned antibacterial and antiviral particles are used to treat the non-woven fabric using a padding process (the concentration of the antibacterial and antiviral particles based on polyquaternary ammonium salt in the coating liquid is 1%, the liquid carrying rate in the padding process is 100%, the drying temperature is 120°C, and the drying time is 10 minutes) to obtain an antibacterial and antiviral functionalized non-woven fabric.

[0083] Embodiments 3 to 8

[0084] The nonionic surfactant used is 1% of the monomer content and is selected from at least one of Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60 and Tween 80, and the total monomer concentration is controlled at 30%.

[0085] The monomer feed and polymer compositions of Examples 1 to 8 are as follows:

[0086]

[0087]

[0088] Comparative Examples 1 to 3

[0089] The nonionic surfactant used is 1% of the monomer content, and is selected from at least one of Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60, and Tween 80, and the total monomer concentration is controlled at 30%. The monomer feed and polymer composition of Comparative Examples 1 to 3 are as follows:

[0090]

[0091] The antibacterial and antiviral particles obtained by the aggregated ammonium salts obtained in Examples 1 to 8 and Comparative Examples 1 to 3 were subjected to solvent solubility, particle size, potential, antibacterial, antiviral, and in vitro cytotoxicity tests. The characterization method was the same as that in Example 2, and the results were as follows:

[0092]

[0093] The above results show that: in comparative example 1, (a+b) / n<0.6 and 0.1≤a / (a+b)≤0.5, the polymer particles show weak antibacterial and antiviral properties, but strong in vitro cytotoxicity; in comparative example 2, (a+b) / n≥0.6 and a / (a+b)<0.1, the polymer particles show weak antibacterial and antiviral properties, and the in vitro cytotoxicity is also small; in comparative example 3, (a+b) / n≥0.6 and a / (a+b)>0.5, the polymer particles show strong antibacterial and antiviral properties, and the in vitro cytotoxicity is also strong.

[0094] In addition to the differences in the components of the polyquaternary ammonium salt and the types of surfactants used, which will affect the particle size, the particle size can also be effectively controlled by adjusting the concentration of the surfactant during the reaction.

[0095] Comparative Examples 4 to 6 differ from Example 1 in that different amounts of surfactants are added: Comparative Example 4 adds Tween 80 (4.0 g); Comparative Example 5 adds Tween 80 (8.0 g); and Comparative Example 6 adds Tween 80 (1.0 g).

[0096] The composition and performance characterization results of the aggregated ammonium salts obtained in Comparative Examples 4 to 6 are as follows:

[0097]

[0098] From the results, it is found that the in vitro cytotoxicity of Comparative Examples 4 and 5 is slightly greater, which is related to the particle size of the polyquaternium salt; in addition, although the antibacterial and antiviral activities are both >99%, there are also slight differences. For example, the actual antibacterial value of Example 1 is 99.95%, while that of Comparative Examples 4 to 6 is 99.990%, 99.993%, and 99.85%, respectively, indicating that the smaller the particle size, the better the antibacterial performance.

[0099] Example 9

[0100] S1. Methacryloyloxyethyl trimethylammonium chloride (4.1 g, 20 mM), octyl methacrylate (9.9 g, 50 mM), methyl methacrylate (3.0 g, 29.5 mM), N-hydroxymethyl acrylamide (0.05 g, 0.5 mM), Tween 80 (2.0 g) and deionized water (40 g) were added to a reaction bottle and mixed, mechanically stirred for 30 min under a nitrogen atmosphere, then heated to 75 ° C, and then APS aqueous solution (5 mL, 0.5 mol / L) was added dropwise. After reacting for 6 hours, the antibacterial and antiviral particles were obtained after cooling, purification and drying; or after purification, they were redispersed in water to obtain an antibacterial and antiviral particle dispersion.

[0101] S2. Add the reactive component (glutaraldehyde) solution (10 mL, 1%) to the antibacterial and antiviral particle dispersion (100 mL, 10%) obtained in S1, and react at 60°C for 8 hours; after the reaction is completed, purify and dry to obtain the antibacterial and antiviral particles; or purify and redisperse in water to obtain the antibacterial and antiviral particle dispersion.

[0102] Characterization of polymer structure and properties:

[0103] (1) Structural characterization: The copolymer structure of the antibacterial and antiviral particles obtained in step S1 was analyzed by 1H-NMR; the particle size of the antibacterial and antiviral particles was measured by laser dynamic light scattering;

[0104] (2) Performance characterization: The surface potential of the antibacterial and antiviral particles was tested using the particle potential test mode of a laser dynamic light scattering instrument.

[0105] The antibacterial and antiviral particles obtained in S2 are treated with a non-woven fabric using a padding process (the concentration of the antibacterial and antiviral particles based on polyquaternary ammonium salt in the coating liquid is 1%, the liquid rate in the padding process is 100%, the drying temperature is 120°C, and the drying time is 10 minutes) to obtain an antibacterial and antiviral functionalized non-woven fabric.

[0106] The antibacterial and antiviral functionalized nonwoven fabrics were evaluated for their antibacterial and antiviral properties, antiviral activity, and biocompatibility. The distribution of antibacterial and antiviral particles on the nonwoven fabric fibers was observed using a scanning electron microscope.

[0107] Embodiments 9 to 16

[0108] The nonionic surfactant used is 1% of the monomer content and is selected from at least one of Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60 and Tween 80, and the total monomer concentration is controlled at 30%.

[0109] In Example 10, the reactive component is glutaraldehyde. In Example 11, the reactive component is glutaraldehyde. In Example 12, the reactive component is selected from one or more of ethylenediamine, diethylenediamine, and dibutylene diamine. In Example 13, the reactive component is p-dichlorobenzyl. In Example 14, the reactive component is selected from one or more of glutaraldehyde, ethylenediamine, diethylenediamine, and dibutylene diamine. In Example 15, the reactive component is selected from one or more of glutaraldehyde, diacetone acrylamide, and ethyl methacrylate. In Example 16, the reactive component is selected from one or more of glutaraldehyde, dithiocapryl polyethylene glycol, dimercaptosuccinic acid, and 2,5-dimercaptoterephthalic acid.

[0110] The monomer feed and polymer compositions of Examples 9 to 16 are as follows:

[0111]

[0112]

[0113] Comparative Examples 7 to 9

[0114] The nonionic surfactant used is 1% of the monomer content and is selected from at least one of Span 20, Span 40, Span 60, Span 80, Tween 20, Tween 40, Tween 60 and Tween 80, and the total monomer concentration is controlled at 30%.

[0115] In Comparative Example 7, the reactive component is selected from one or more of diacetone acrylamide and ethyl acetoacetate methacrylate; in Comparative Examples 8 to 9, the reactive component is selected from one or more of ethylenediamine, diethylenediamine and dibutylene diamine.

[0116] The monomer feed and polymer compositions of Comparative Examples 7 to 9 are as follows:

[0117]

[0118]

[0119] The antibacterial and antiviral particles formed by the reaction products of the aggregated ammonium salts obtained in Examples 9 to 16 and Comparative Examples 7 to 9 and the corresponding reactive components were subjected to solvent solubility, particle size, potential, antibacterial, antiviral, and in vitro cytotoxicity tests. The characterization method was the same as in Example 2, and the results were as follows:

[0120]

[0121]

[0122] The above results show that: in Comparative Example 7, (a+b) / n<0.6 and 0.1≤a / (a+b)≤0.5, the polymer particles show weak antibacterial and antiviral properties, but strong in vitro cytotoxicity; in Comparative Example 8, (a+b) / n≥0.6 and a / (a+b)<0.1, the polymer particles show weak antibacterial and antiviral properties, and the in vitro cytotoxicity is also small; in Comparative Example 9, (a+b) / n≥0.6 and a / (a+b)>0.5, the polymer particles show strong antibacterial and antiviral properties, and the in vitro cytotoxicity is also strong.

[0123] Embodiment 17

[0124] The aggregated ammonium salt obtained in Example 10 was used to prepare antibacterial and antiviral particles according to the following steps: 10g of polyvinyl alcohol, 50g of polyquaternary ammonium salt, and 10g of glucose were added to 300g of deionized water and stirred evenly, 10g of tetrabutyl titanate was added thereto, and stirred at a speed of 500r / min for 1min. 10g of 15% ammonia water was added dropwise thereto under stirring, and stirring was continued for 1h. The mixture was sent into a hydrothermal reactor with a polytetrafluoroethylene lining, treated at a temperature of 95°C for 15h, filtered, washed with deionized water, and dried.

[0125] Embodiment 18

[0126] The aggregated ammonium salt obtained in Example 10 was used to prepare antibacterial and antiviral particles according to the following steps: 20g of polyvinyl alcohol, 100g of polyquaternary ammonium salt, and 30g of glucose were added to 1000g of deionized water and stirred evenly, 30g of tetrabutyl titanate was added thereto, and stirred at a speed of 1500r / min for 5min. Under stirring, 20g of 20% ammonia water was added dropwise thereto, and stirring was continued for 2h. The mixture was sent into a hydrothermal reactor with a polytetrafluoroethylene lining, treated at a temperature of 110°C for 10h, filtered, washed with deionized water, and dried.

[0127] Embodiment 19

[0128] The aggregated ammonium salt obtained in Example 10 was used to prepare antibacterial and antiviral particles according to the following steps: 15 g of polyvinyl alcohol, 80 g of polyquaternary ammonium salt, and 20 g of glucose were added to 650 g of deionized water and stirred evenly, 50 g of tetrabutyl titanate was added thereto, and stirred at a speed of 1000 r / min for 3 min. 15 g of ammonia water with a mass fraction of 16% was added dropwise thereto under stirring, and stirring was continued for 90 min. The mixture was sent into a hydrothermal reactor with a polytetrafluoroethylene lining, treated at a temperature of 105°C for 13 h, filtered, washed with deionized water, and dried.

[0129] Comparative Example 10

[0130] The aggregated ammonium salt obtained in Example 10 was used to prepare antibacterial and antiviral particles according to the following steps: 15 g of polyvinyl alcohol and 20 g of glucose were added to 650 g of deionized water and stirred evenly, 50 g of tetrabutyl titanate was added thereto, and stirred at a speed of 1000 r / min for 3 min. 15 g of 16% ammonia water was added dropwise thereto under stirring, and stirring was continued for 90 min. Then 80 g of polyquaternary ammonium salt was added, and the mixture was sent to a hydrothermal reactor with a polytetrafluoroethylene lining, treated at a temperature of 105°C for 13 h, filtered, washed with deionized water, and dried.

[0131] Comparative Example 11

[0132] The antibacterial and antiviral particles were prepared using the aggregated ammonium salt obtained in Example 10 according to the following steps: 15 g of polyvinyl alcohol, 80 g of polyquaternary ammonium salt, and 20 g of glucose were added to 650 g of deionized water and stirred evenly, 50 g of tetrabutyl titanate was added thereto, and stirred at a speed of 1000 r / min for 3 min. 15 g of 16% ammonia water was added dropwise thereto under stirring, and stirring was continued for 90 min. The mixture was filtered, washed with deionized water, and dried.

[0133] The antibacterial and antiviral particles obtained in Examples 17 to 19 and Comparative Examples 10 to 11 were used for in vitro cytotoxicity tests. It was found that the antibacterial and antiviral particles obtained in Examples 17 to 19 were of level 0, while the antibacterial and antiviral particles obtained in Comparative Examples 10 to 11 were of level 1, which were similar to the in vitro cytotoxicity of the antibacterial and antiviral particles obtained in Example 10. The antibacterial rates of the three particles against Escherichia coli were all greater than 99%, and the antiviral activity rates against influenza A virus H1N1 were all greater than 99%. The results show that the titanium dioxide "carbonized layer" on the outer surface of the polyquaternary ammonium salt particles is beneficial to improving the biocompatibility of the antibacterial and antiviral particles.

[0134] The antibacterial and antiviral particles obtained in Examples 10 and 19 were dispersed in water with a mass fraction of 0.01%, and irradiated under ultraviolet light for 0 min, 10 min, 30 min, 60 min, and 360 min, respectively. 9 mL of nutrient broth was added to 1 mL of each sample dispersion treated with different irradiation times, and 0.1 mL of 10 8 cfu / mL of Staphylococcus aureus suspension, shake well. The blank control does not contain the sample dispersion. All samples are placed in a 37°C incubator for 18 hours, the number of live bacteria in all samples is calculated, and then the logarithmic change value (LgDP) of the number of bacteria in each group of samples relative to the blank control group is calculated to characterize the change in its antibacterial activity.

[0135] LgDP=LgN0-LgN

[0136] Wherein, N0 is the bacterial count in the blank control group, and N is the bacterial count in each group of samples.

[0137] like Figure 2 As shown in the figure, with the change of ultraviolet light irradiation time, the antibacterial activity of each group of antibacterial and antiviral particles continued to decrease. However, compared with the antibacterial and antiviral particles obtained in Example 10, the antibacterial and antiviral particles obtained in Example 19 have a very small range of antibacterial activity, which proves that the antibacterial and antiviral particles obtained in the present invention have good stability to ultraviolet light irradiation.

[0138] The applicant believes that this is because the present invention disperses polyquaternary ammonium salt in water, deposits nano-titanium dioxide particles on its surface, and then forms a carbonized layer bonded to the surface through hydrothermal treatment, which can effectively "shield" the destructive effect of polyquaternary ammonium salt on biological cell membranes. Experiments have also found that the antibacterial and antiviral particles can exhibit stronger antibacterial properties and better biocompatibility than polyquaternary ammonium salts; and have better UV resistance.

[0139] The above description is only a preferred specific implementation manner of the present invention, but the protection scope of the present invention is not limited thereto. Any technician familiar with the technical field can make equivalent replacements or changes according to the technical scheme and inventive concept of the present invention within the technical scope disclosed by the present invention, which should be covered by the protection scope of the present invention.

Claims

1. A polyquaternary ammonium salt, characterized in that At least including: segment A, segment B and segment C; The side chain of segment A contains a quaternary ammonium salt group, the side chain of segment B contains a C8-C22 alkyl chain, and the side chain of segment C contains at least one of a C1-C6 alkyl chain, a phenyl group, a cyano group, a carboxyl group, and a sulfonic acid group; Wherein, the sum of the number of repeating units of each segment in the polyquaternary ammonium salt is n, the number of repeating units of segment A is a, and the number of repeating units of segment B is b, then n, a, and b meet the following relationship: (a+b) / n≥0.6, and 0.1≤a / (a+b)≤0.

5.

2. The polyquaternium salt according to claim 1, characterized in that If the side chain of segment B is a C8-C14 alkyl chain, then 0.1≤a / (a+b)≤0.4; if the side chain of segment B is a C16-C22 alkyl chain, then 0.2≤a / (a+b)≤0.

5.

3. The polyquaternium salt according to claim 1, characterized in that The reactive monomer of the A segment is at least one of (meth)acryloyloxyethyl trimethyl ammonium chloride, (meth)acryloyloxyethyl trimethyl ammonium bromide, (meth)acryloyloxyethyl trimethyl ammonium iodide, (meth)acryloyloxyethyl dimethyl benzyl ammonium chloride, (meth)acryloyloxyethyl dimethyl benzyl ammonium bromide, (meth)acryloyloxyethyl dimethyl benzyl ammonium iodide, (meth)acryloyloxyethyl dimethyl isopropyl ammonium chloride, (meth)acryloyloxyethyl dimethyl isopropyl ammonium bromide, and (meth)acryloyloxyethyl dimethyl isopropyl ammonium iodide; preferably (meth)acryloyloxyethyl dimethyl benzyl ammonium chloride, (meth)acryloylethoxy dimethyl benzyl ammonium bromide or / and (meth)acryloyloxyethyl dimethyl benzyl ammonium iodide; Preferably, the reactive monomer of the B segment is at least one of octyl (meth)acrylate, decyl (meth)acrylate, dodecyl (meth)acrylate, tetradecyl (meth)acrylate, hexadecyl (meth)acrylate, octadecyl (meth)acrylate, eicosyl (meth)acrylate, and docosyl (meth)acrylate; Preferably, the reactive monomer of the C segment is at least one of methyl (meth)acrylate, butyl acrylate, methacrylic acid, styrene, acrylonitrile, allyl polypropylene glycol ether, and 2-acrylamide-2-methylpropane sulfonic acid.

4. The polyquaternium salt according to claim 1, characterized in that It also includes a D segment, wherein the side chain of the D segment contains at least one of a hydroxyl group, an amine group, an epoxy group, an azido group, a hydroxymethyl group, an organosilicon group, and a carbon-carbon double bond; The number of repeating units of segment D is d, then 0.005≤d / n≤0.1; Preferably, the reactive monomer of the D segment is at least one of hydroxymethyl methacrylamide, hydroxyethyl methacrylamide, hydroxyethyl methacrylate, glycidyl methacrylate, N,N-dimethylaminoethyl methacrylate, methacryloxytrimethoxysilane, methacryloxytriethoxysilane, methacryloxytriisopropoxysilane, diacetone acrylamide, acetoacetoxyethyl methacrylate, and methacrylate polyethylene glycol azide.

5. An antibacterial and antiviral particle, characterized in that: include: The polyquaternary ammonium salt according to any one of claims 1 to 3, wherein the polyquaternary ammonium salt consists only of segment A, segment B and segment C.

6. An antibacterial and antiviral particle, characterized in that: include: The reaction product of the polyquaternary ammonium salt and a reactive component as claimed in any one of claims 1 to 4, wherein the polyquaternary ammonium salt consists of an A segment, a B segment, a C segment and a D segment.

7. The antibacterial and antiviral particle according to claim 6, characterized in that: The reactive component is at least one of glutaraldehyde, hexamethylene diisocyanate, isophorone diisocyanate, toluene diisocyanate, ethylenediamine, diethylenediamine, dibutylene diamine, diacetone acrylamide, ethyl acetoacetate methacrylate, dithiocapryl polyethylene glycol, dimercaptosuccinic acid and 2,5-dimercaptoterephthalic acid.

8. The antibacterial and antiviral particle according to claim 5, or the antibacterial and antiviral particle according to any one of claims 6 to 7, characterized in that: It can be dispersed in water; its particle size is 20 to 2000 nm and its surface potential is 10 to 80 mV.

9. An antibacterial and antiviral particle, characterized in that: The preparation method is prepared by the following specific steps: adding polyvinyl alcohol, the polyquaternary ammonium salt according to any one of claims 1 to 4 and glucose into deionized water and stirring evenly, adding tetrabutyl titanate thereto and stirring for 1 to 5 minutes, adding ammonia water dropwise thereto under stirring, continuing stirring for 1 to 2 hours, hydrothermally reacting at 95 to 110° C. for 10 to 15 hours, filtering, washing with water and drying.

10. Use of the antibacterial and antiviral particles according to claim 5, or the antibacterial and antiviral particles according to any one of claims 6 to 7, or the antibacterial and antiviral particles according to claim 9 in textiles, plastics, fibers, and medical devices.

Citation Information

Patent Citations

  • Hydrophobic polyquaternary-ammonium-salt antistatic agent for oil products and preparation method of hydrophobic polyquaternary-ammonium-salt antistatic agent

    CN106190369A

  • Quaternary phosphonium salt-containing polyacrylic acid emulsion with antibacterial function as well as preparation method and application of quaternary phosphonium salt-containing polyacrylic acid emulsion

    CN115340627A

  • Antifouling agent

    US4526932A